Pfizer is licensing a promising investigational cancer medicine from a smaller company. This move improves the drugmaker's ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

With COVID-19 still an ongoing global threat, Kennedy's policies are not only dangerously anti-scientific but actively ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

As New Zealand eyes a free trade agreement with India, experts say the next frontier could be pharmaceutical imports - ...

The HHS leader has a different view of health and wellness, and that's teasing out some tantalizing opportunities for ...

Microsoft Scientific Discovery is an AI-powered research-focused platform designed for scientists, research institutions, and ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

We came across a bullish thesis on Fulcrum Therapeutics, Inc. (FULC) on Stock Pursuit’s Substack. In this article, we will ...